Fort Sam Houston

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia3 trials
• Diffuse large B-cell lymphoma1 trial
• Lung cancer1 trial

Phase

• Phase 35 trials

Status

• Active, not recruiting5 trials

Lead sponsor

• Acerta Pharma BV4 trials
• AstraZeneca1 trial

Running trials

• Active, not recruiting

  A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

  NCT05211895· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)

  NCT04529772· Phase 3· Acerta Pharma BV· Source

• Active, not recruiting

  Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

  NCT03836261· Phase 3· Acerta Pharma BV· Source

• Active, not recruiting

  A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL

  NCT02970318· Phase 3· Acerta Pharma BV· Source

• Active, not recruiting

  Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL

  NCT02475681· Phase 3· Acerta Pharma BV· Source